3-fluoro-N-benzyl-D-galactonoamidine

ID: ALA3359668

PubChem CID: 136912375

Max Phase: Preclinical

Molecular Formula: C13H17FN2O4

Molecular Weight: 284.29

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  OC[C@H]1N/C(=N\Cc2cccc(F)c2)[C@H](O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C13H17FN2O4/c14-8-3-1-2-7(4-8)5-15-13-12(20)11(19)10(18)9(6-17)16-13/h1-4,9-12,17-20H,5-6H2,(H,15,16)/t9-,10+,11+,12-/m1/s1

Standard InChI Key:  IEMXTXDXUYPRHU-NOOOWODRSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   32.2254   -3.5412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2254   -4.3584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9307   -4.7628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6360   -4.3584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6360   -3.5412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9307   -3.1284    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3449   -3.1346    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3431   -4.7680    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.9307   -5.5800    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.5183   -4.7680    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.5165   -3.1346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5141   -2.3175    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3473   -2.3175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0562   -1.9109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7660   -2.3261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4744   -1.9203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4773   -1.1022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7658   -0.6950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0603   -1.0999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1807   -2.3313    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  4  8  1  6
  3  9  1  1
  2 10  1  1
  1 11  1  1
 11 12  1  0
  7 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 16 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3359668

    ---

Associated Targets(non-human)

Beta-galactosidase (59 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLB1 Beta-galactosidase (500 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 284.29Molecular Weight (Monoisotopic): 284.1172AlogP: -1.23#Rotatable Bonds: 3
Polar Surface Area: 105.31Molecular Species: NEUTRALHBA: 5HBD: 5
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 12.52CX Basic pKa: 7.30CX LogP: -1.26CX LogD: -1.51
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.48Np Likeness Score: 0.09

References

1. Fan QH, Claunch KA, Striegler S..  (2014)  Structure-activity relationship of highly potent galactonoamidine inhibitors toward β-galactosidase (Aspergillus oryzae).,  57  (21): [PMID:25295392] [10.1021/jm501111y]
2. Pickens JB, Striegler S, Fan QH..  (2016)  Arabinoamidine synthesis and its inhibition toward β-glucosidase (sweet almonds) in comparison to a library of galactonoamidines.,  24  (16): [PMID:27298003] [10.1016/j.bmc.2016.04.069]
3. Pickens JB, Wang F, Striegler S..  (2017)  Picomolar inhibition of β-galactosidase (bovine liver) attributed to loop closure.,  25  (20): [PMID:28844803] [10.1016/j.bmc.2017.07.020]

Source